Literature DB >> 11333602

[Aeromonas spp bacteremia: study of 12 cases and review of the literature].

C Campo1, V Navarro, C Pérez, I Gutiérrez, R Alonso.   

Abstract

Twelve cases of Aeromonas spp. bacteremia are here reviewed in adult patients occurred at our institution during a 6-year period. Three cases corresponded to patients with hematological disease and four had a solid neoplasm. The source of infection in seven patients was extra-nosocomial; infections in the five remaining patients were considered to be acquired in the hospital. In seven patients, potential portals of entry were found. The usual clinical presentation was febrile syndrome in all cases and only in two patients did the clinical picture evolve to fulminant septic shock. Speciation of microorganisms was determined in only four cases: 2 A. hydrophilia, 1 A. caviae, and 1 A. veronii. Most isolates were susceptible to aminoglycosides, cotrimozazol, phosphomycin, and quinolonos, and resistant to ampicillin. Three patients (25%) died as a result of the infection. Aeromonas spp. bacteremia represented 0.12% of blood cultures in our hospital and occurs in immunosuppressed patients although it may be reported in previously healthy individuals.

Entities:  

Mesh:

Year:  2001        PMID: 11333602     DOI: 10.1016/s0213-005x(01)72596-7

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  3 in total

1.  Prospective nationwide study of Aeromonas infections in France.

Authors:  Brigitte Lamy; Angeli Kodjo; Frédéric Laurent
Journal:  J Clin Microbiol       Date:  2009-02-25       Impact factor: 5.948

2.  Clinical and Therapeutic Implications of Aeromonas Bacteremia: 14 Years Nation-Wide Experiences in Korea.

Authors:  Ji Young Rhee; Dong Sik Jung; Kyong Ran Peck
Journal:  Infect Chemother       Date:  2016-12

3.  Clinical significance and outcome of Aeromonas spp. infections among 204 adult patients.

Authors:  J Nolla-Salas; J Codina-Calero; S Vallés-Angulo; A Sitges-Serra; A Zapatero-Ferrándiz; M C Climent; J Gómez; J R Masclans
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-03-03       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.